| http://www.w3.org/ns/prov#value | - Studies of phosphodiesterase inhibitors used in smaller populations of women with specific medical conditions, such as diabetes and multiple sclerosis have been more encouraging.Femprox has successfully completed seven clinical trials, including one, 98-subject Phase II study in the United States and a Phase III study in China comprised of over 300 women.On May 24, 2005, Apricus announced the prel
|
